Expert Pitch
Florida State University

FSU experts available to discuss pandemic’s impact on elections

3-Apr-2020 12:10 PM EDT, by Florida State University

By: Mark Blackwell Thomas | Published: | 9:41 am |

As coronavirus continues to upend day-to-day life, the upcoming 2020 elections will also be affected. In Ohio, where the governor canceled that state’s primaries, we see one vivid example of how the global pandemic has already impacted elections here in America.  

Incumbents and candidates are facing the prospect of campaigning without traditional tools, such as national conventions, rallies and door-to-door outreach. In a world where social distancing is the new normcampaigns are forced to adjust their strategies and tactics to help persuade an electorate living through a time in American history without precedent.   

Experts at Florida State University can help provide context and perspective on how this will shape the 2020 elections from the local, statewide and national perspectives. 

Hans Hassell, assistant professor, Department of Political Science

Hassell’s research focuses on political institutions and specifically on political parties and their role in electoral politics. 

Campaign tactics have evolved significantly over the past few decades and these adaptations have fundamentally changed the scope of conflict in political campaigns. Our current situation will also fundamentally affect how candidates campaign, the voters they reach, and ultimately the dynamics of citizen involvement in elections. 

Matt Pietryka, assistant professor, Department of Political Science
 

Pietryka’s research focuses on understanding how the social and political contexts of life influence the political attitudes and behavior of individuals. In particular, he studies how political discussion with friends and family can affect individual political behavior. 

“I am currently studying voting and elections so I can discuss the implications of COVID-19 on the November elections.”  

Randall Holcombe, DeVoe Moore Professor of Economics

Holcombe is the author of 15 books and 150 articles published in academic and professional journalsHis primary areas of research are the economic analysis of public policy and public finance. 

 “Biden and Trump will be their party nominees, and one question is whether the conventions will be held this summer. Whether the pandemic helps or hurts Trump depends on how he handles things. So far, I think things have worked in his favor, but if the crisis atmosphere goes on many more months, people are likely to become uneasy.” 




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.51442